On the other hand, I. Hachim et al. found that the expression of PRL-R is reduced in invasive BC (21.4%), compared with BBT (80%) and carcinoma in situ (60%) (p = 0.003498) [21]. The gene discussed is PRLR; the disease is breast cancer.